Impact of interferon-free antivirus therapy on lipid profiles in patients with chronic hepatitis C genotype 1bDaisuke Endo, Yoshio Aizawa, Kenichi Satoh et al.|World Journal of Gastroenterology|2017Cited by 64
Lenvatinib versus Sorafenib as first‐line treatment in hepatocellular carcinoma: A multi‐institutional matched case‐control studyMargherita Rimini, Andrea Casadei‐Gardini, Atsushi Hiraoka et al.|Hepatology Research|2021Cited by 46
Adverse events as potential predictive factors of activity in patients with advanced hepatocellular carcinoma treated with lenvatinibIlario Giovanni Rapposelli, Margherita Rimini, Toshifumi Tada et al.|Liver International|2021Cited by 25
Clinical Significance of Two Real-Time PCR Assays for Chronic Hepatitis C Patients Receiving Protease Inhibitor-Based TherapyTakako Inoue, Yasuhito Tanaka, Su Su Hmwe et al.|PLoS ONE|2017Cited by 2